新規登録 | ログイン | FAQ      [?] 

タグ: her2 [23 articles]

Recent papers classified by the tag her2.
  • HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy
    International Journal of Cancer, Vol. 122, No. 5. (2008), pp. 999-1004.
    by Alfredo Santinelli, Eleonora Pisa, Daniela Stramazzotti, Guidalberto Fabris
    posted to metastasis therapy prospective immune-evasion histopath her2 cancer breast by Zephyrus on 2008-09-16 20:49:49 as **
  • Signatures Associated with Rejection or Recurrence in HER-2/neu-Positive Mammary Tumors
    Cancer Res, Vol. 68, No. 7. (1 April 2008), pp. 2436-2446.
    by Andrea Worschech, Maciej Kmieciak, Keith L Knutson, Harry D Bear, Aladar A Szalay, Ena Wang, Francesco M Marincola, Masoud H Manjili
    posted to thesis th2 th1 t-cells recurrence immunology her2 cancer breast by Zephyrus on 2008-10-04 10:15:13 as ****
  • Does HER-2/neu antigen loss in metastatic breast tumors occur under immune pressure?
    International journal of cancer. Journal international du cancer, Vol. 123, No. 6. (15 September 2008)
    by MH Manjili, M Kmieciak
    posted to journal-club immunology immune-evasion her2 cancer breast by Zephyrus on 2008-09-16 21:40:08 as **
  • HER-2/neu antigen loss in metastatic breast tumors - A pathological point of view
    International Journal of Cancer, Vol. 123, No. 6. (2008), pp. 1478-1479.
    by Alfredo Santinelli, Eleonora Pisa, Daniela Stramazzotti, Guidalberto Fabris
    posted to metastasis pathology journal-club her2 cancer breast by Zephyrus on 2008-09-16 22:47:17 as **
  • Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.
    J Cell Biochem, Vol. 86, No. 1. (2002), pp. 174-183.
    by DG Bosc, R Janknecht
    posted to her2 target transcription_factor by tuck on 2006-02-07 14:00:46 as **
  • The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
    Oncogene, Vol. 16, No. 3. (22 January 1998), pp. 301-310.
    by RC O'Hagan, JA Hassell
    posted to her2 transcription transcription_factor by tuck on 2006-02-07 13:52:13 as **
  • Activity of Suberoylanilide Hydroxamic Acid Against Human Breast Cancer Cells with Amplification of Her-2
    Clin Cancer Res, Vol. 11, No. 17. (1 September 2005), pp. 6382-6389.
    by Purva Bali, Michael Pranpat, Ramona Swaby, Warren Fiskus, Hirohito Yamaguchi, Maria Balasis, Kathy Rocha, Hong-Gang Wang, Victoria Richon, Kapil Bhalla
    posted to akt hdac her2 by tuck on 2006-02-07 13:57:16 as **
  • Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
    Genome Biol, Vol. 6, No. 10. (2005)
    by S Huang, Y Li, Y Chen, K Podsypanina, M Chamorro, AB Olshen, KV Desai, A Tann, D Petersen, JE Green, HE Varmus
    posted to breast cancer her2 wnt by tuck on 2007-01-04 16:16:24 as **
  • Forkhead Box Transcription Factor FOXO3a Regulates Estrogen Receptor Alpha Expression and Is Repressed by the Her-2/neu/Phosphatidylinositol 3-Kinase/Akt Signaling Pathway
    Mol. Cell. Biol., Vol. 24, No. 19. (1 October 2004), pp. 8681-8690.
    by Shangqin Guo, Gail E Sonenshein
    posted to her2 target transcription_factor by tuck on 2006-02-07 13:54:36 as **
  • A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 11, No. 13. (1 July 2005), pp. 4775-4778.
    by W Han, D Kang, JE Lee, IA Park, JY Choi, KM Lee, JY Bae, S Kim, ES Shin, JE Lee, HJ Shin, SW Kim, SW Kim, DY Noh
    posted to survival prognosis korean her2 breast by misonneh on 2008-09-24 19:54:45 as read
  • ETS transcription factors and their emerging roles in human cancer.
    Eur J Cancer, Vol. 41, No. 16. (November 2005), pp. 2462-2478.
    by A Seth, DK Watson
    posted to review her2 ets esx cancer by mapplab on 2008-10-06 16:15:38 as ** along with 1 person jyuh
  • HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
    Breast Cancer Research, Vol. 9 (02 March 2007), 205.
    by Neil Spector, Wenle Xia, Iman El-Hariry, Yossi Yarden, Sarah Bacus
    posted to cancer her2 inhibitor tki by klu on 2007-09-24 16:22:39 as ** along with 1 person pjasper
  • Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression.
    Cancer Res, Vol. 67, No. 3. (1 February 2007), pp. 1228-1238.
    by G Schaefer, L Shao, K Totpal, RW Akita
    posted to cancer egfr erlotinib her2 hrg by klu on 2007-07-27 18:20:08 as ** along with 1 person pjasper
  • Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis
    Nature Genetics, Vol. 39, No. 3. (28 January 2007), pp. 338-346.
    by Sofi G Julien, Nadia Dubé, Michelle Read, Janice Penney, Marilene Paquet, Yongxin Han, Brian P Kennedy, William J Muller, Michel L Tremblay
    posted to cancer her2 phosphatase ptp1b by klu on 2007-08-16 21:32:15 as **
  • Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis
    British Journal of Cancer, Vol. aop, No. current. (07 November 2006)
    by H Yokoyama, Y Ikehara, Y Kodera, S Ikehara, Y Yatabe, Y Mochizuki, M Koike, M Fujiwara, A Nakao, M Tatematsu, H Nakanishi
    posted to egfr gefitinib her2 tki by klu on 2007-07-26 19:35:14 as ** along with 1 person pjasper
  • Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
    Cancer Res, Vol. 67, No. 6. (15 March 2007), pp. 2420-2424.
    by M Bentires-Alj, BG Neel
    posted to cancer her2 inhibitor phosphatase ptp1b by klu on 2007-08-16 21:31:17 as ** along with 1 person pjasper
  • Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
    BMC Cancer, Vol. 8 (06 February 2008), 42.
    by Nuran Bektas, Anette T Haaf, Jürgen Veeck, Peter J Wild, Juliane Lüscher-Firzlaff, Arndt Hartmann, Ruth Knüchel, Edgar Dahl
    posted to tissue prognosis microarray immunohistochemistry her2neu her2 foxm1 cancer breast biomarker by Juergen_Veeck on 2008-02-23 18:06:55 as read
  • Close association between HER-2 amplification and overexpression in human tumors of non-breast origin.
    Mod Pathol, Vol. 20, No. 2. (February 2007), pp. 192-198.
    by C Tapia, K Glatz, H Novotny, A Lugli, M Horcic, CA Seemayer, L Tornillo, L Terracciano, H Spichtin, M Mirlacher, R Simon, G Sauter
    posted to cancer her2 nanoshells by jjohnson17 on 2007-10-05 19:28:17 as **
  • Clinical significance of Akt and HER2/neu overexpression in African American and Latina women with breast cancer: a retrospective cohort study
    Breast Cancer Research, Vol. 10 (10 January 2008), R3.
    by Yanyuan Wu, Hezla Mohamed, Ram Chillar, Ishrat Ali, Sheila Clayton, Denis Slamon, Jaydutt V Vadgama
    posted to akt and her2 by jayvadgama on 2008-02-08 09:09:26 as *****
  • HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.
    Bioconjug Chem, Vol. 17, No. 5. (t 2006), pp. 1109-1115.
    by R Shukla, TP Thomas, JL Peters, AM Desai, J Kukowska-Latallo, AK Patri, A Kotlyar, JR Baker
    posted to her2 dendrimer by eeruowl to the group UFS on 2007-06-04 22:43:03 as **
  • Molecular portraits of human breast tumours.
    Nature, Vol. 406, No. 6797. (17 August 2000), pp. 747-752.
    by CM Perou, T Sørlie, MB Eisen, M van de Rijn, SS Jeffrey, CA Rees, JR Pollack, DT Ross, H Johnsen, LA Akslen, O Fluge, A Pergamenschikov, C Williams, SX Zhu, PE Lønning, AL Børresen-Dale, PO Brown, D Botstein
    posted to unsupervised molecular_classification luminal her2 breast_cancer basel by frohike on 2008-04-18 13:45:48 as ** along with 4 people misonneh ruszczyk jfr evaf
  • HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways.
    Cell Cycle, Vol. 4, No. 1. (January 2005), pp. 87-95.
    by XF Le, F Pruefer, RC Bast
    posted to antibody breast cancer her2 monoclonal signal targeted therapy transduction by franzpruefer on 2006-02-20 20:51:28 as *****
  • A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.
    Cancer research, Vol. 67, No. 15. (1 August 2007), pp. 7477-7486.
    by HJ Ko, YJ Kim, YS Kim, WS Chang, SY Ko, SY Chang, S Sakaguchi, CY Kang
    posted to ctl gemcitabine her2 mice tolerance treg by eisei on 2008-05-02 11:12:41 as **
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/tag/her2

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.